Resultado de búsqueda
17 de abr. de 2024 · At Uppsala Monitoring Centre (UMC), we promote the safer use of medicines globally in close collaboration with the World Health Organization (WHO). We do this by bringing operational support to WHO and our stakeholders, and through our research activities and the development of innovative tools and solutions. We advance the science and practice ...
Uppsala Monitoring Centre (UMC) is an independent foundation that advances the science of pharmacovigilance globally and serves as a WHO Collaborating Centre supporting the WHO Programme for International Drug Monitoring. UMC’s primary website contains information about the centre’s scientific, operational, educational, and communication ...
Developing the science of pharmacovigilance has been a key priority for Uppsala Monitoring Centre for over four decades. The science behind identifying and preventing harm to patients At UMC we work to develop the best possible tools for pharmacovigilance in general and in support of all member countries in the WHO PIDM.
Uppsala Monitoring Centre (UMC) UMC was established in Uppsala, Sweden in 1978 as the World Health Organization (WHO) Collaborating Centre for International Drug Monitoring. UMC operates the technical and scientific aspects of the WHO’s worldwide pharmacovigilance network. Iys main tasks are: providing independent and high-quality medical ...
15 de abr. de 2024 · VigiLyze is a signal detection and signal management tool that uses insights into the safer use of medicines from members of the WHO Programme for International Drug Monitoring (WHO PIDM) as a starting point for efficient quantitative signal detection. It supports national signal management processes, including qualitative assessments.
753 20 Uppsala Sweden. Tel: +46-18-65 60 60. UMC office hours are Monday to Friday 08:30–17:00 CET (CEST). Visits by prior appointment only. Customer support hours are Monday to Friday 09:00–15:00 CET (CEST). Postal address. Uppsala Monitoring Centre Box 1051 751 40 Uppsala SWEDEN
The WHO PIDM is an international collaboration with the goal of ensuring identification of safety problems in medicinal products. With more than 170 full members and associate members, the programme covers about 99% of the world’s population. This is the WHO PIDM.
